{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:28:15Z","timestamp":1764131295770},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00259-007-0704-y","type":"journal-article","created":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T05:21:18Z","timestamp":1202793678000},"page":"70-74","source":"Crossref","is-referenced-by-count":64,"title":["The value of incomplete mouse models of Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"35","author":[{"given":"Rebecca","family":"Radde","sequence":"first","affiliation":[]},{"given":"Cecilia","family":"Duma","sequence":"additional","affiliation":[]},{"given":"Michel","family":"Goedert","sequence":"additional","affiliation":[]},{"given":"Mathias","family":"Jucker","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"704_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L. Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell 2005;120:545\u201355.","journal-title":"Cell"},{"key":"704_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.embor.7400897","volume":"8","author":"B Strooper De","year":"2007","unstructured":"De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 2007;8:141\u20136.","journal-title":"EMBO Rep"},{"key":"704_CR3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2007.10.012","volume":"131","author":"DJ Selkoe","year":"2007","unstructured":"Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell 2007;131:215\u201321.","journal-title":"Cell"},{"key":"704_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","volume":"16","author":"MC Herzig","year":"2006","unstructured":"Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006;16:40\u201354.","journal-title":"Brain Pathol"},{"key":"704_CR5","first-page":"85","volume":"3","author":"AE Roher","year":"2003","unstructured":"Roher AE, Kokjohn TA. Appraisal of AbetaPP transgenic mice as models for Alzheimer\u2019s disease amyloid cascade. Curr Med Chem 2003;3:85\u201390.","journal-title":"Curr Med Chem"},{"key":"704_CR6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/bi015685+","volume":"41","author":"W Kalback","year":"2002","unstructured":"Kalback W, Watson MD, Kokjohn TA, Kuo YM, Weiss N, Luehrs DC, et al. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer\u2019s disease senile plaques. Biochemistry 2002;41:922\u20138.","journal-title":"Biochemistry"},{"key":"704_CR7","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"704_CR8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/nbdi.1999.0243","volume":"6","author":"E McGowan","year":"1999","unstructured":"McGowan E, Sanders S, Iwatsubo T, Takeuchi A, Saido T, Zehr C, et al. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 1999;6:231\u201344.","journal-title":"Neurobiol Dis"},{"key":"704_CR9","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1523\/JNEUROSCI.19-19-08552.1999","volume":"19","author":"AL Phinney","year":"1999","unstructured":"Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 1999;19:8552\u20139.","journal-title":"J Neurosci"},{"key":"704_CR10","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1073\/pnas.222433299","volume":"99","author":"B Urbanc","year":"2002","unstructured":"Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, et al. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer\u2019s disease. Proc Natl Acad Sci USA 2002;99:13990\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"704_CR11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nn1335","volume":"7","author":"J Tsai","year":"2004","unstructured":"Tsai J, Grutzendler J, Duff K, Gan WB. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004;7:1181\u20133.","journal-title":"Nat Neurosci"},{"key":"704_CR12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","volume":"344","author":"MJ West","year":"1994","unstructured":"West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer\u2019s disease. Lancet 1994;344:769\u201372.","journal-title":"Lancet"},{"key":"704_CR13","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J Neurosci 1996;16:4491\u2013500.","journal-title":"J Neurosci"},{"key":"704_CR14","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1523\/JNEUROSCI.17-18-07053.1997","volume":"17","author":"MC Irizarry","year":"1997","unstructured":"Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, et al. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 1997;17:7053\u20139.","journal-title":"J Neurosci"},{"key":"704_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)64544-0","volume":"157","author":"A Takeuchi","year":"2000","unstructured":"Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa M, et al. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 2000;157:331\u20139.","journal-title":"Am J Pathol"},{"key":"704_CR16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/27351","volume":"395","author":"ME Calhoun","year":"1998","unstructured":"Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, et al. Neuron loss in APP transgenic mice. Nature 1998;395:755\u20136.","journal-title":"Nature"},{"key":"704_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert M, Spillantini MG. A century of Alzheimer\u2019s disease. Science 2006;314:777\u201381.","journal-title":"Science"},{"key":"704_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0969-9961(03)00084-6","volume":"14","author":"MA Kurt","year":"2003","unstructured":"Kurt MA, Davies DC, Kidd M, Duff K, Howlett DR. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol Dis 2003;14:89\u201397.","journal-title":"Neurobiol Dis"},{"key":"704_CR19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","volume":"7","author":"R Radde","year":"2006","unstructured":"Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 2006;7:940\u20136.","journal-title":"EMBO Rep"},{"key":"704_CR20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1074\/jbc.M006531200","volume":"276","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, Barmettler R, Nitsch RM. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001;276:529\u201334.","journal-title":"J Biol Chem"},{"key":"704_CR21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000;25:402\u20135.","journal-title":"Nat Genet"},{"key":"704_CR22","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002;22:9340\u201351.","journal-title":"J Neurosci"},{"key":"704_CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9440(10)63997-1","volume":"158","author":"T Ishihara","year":"2001","unstructured":"Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 2001;158:555\u201362.","journal-title":"Am J Pathol"},{"key":"704_CR24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/11154","volume":"2","author":"BT Lamb","year":"1999","unstructured":"Lamb BT, Bardel KA, Kulnane LS, Anderson JJ, Holtz G, Wagner SL, et al. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 1999;2:695\u20137.","journal-title":"Nat Neurosci"},{"key":"704_CR25","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","volume":"96","author":"ME Calhoun","year":"1999","unstructured":"Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999;96:14088\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"704_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005;47:191\u20139.","journal-title":"Neuron"},{"key":"704_CR27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nn1302","volume":"7","author":"MC Herzig","year":"2004","unstructured":"Herzig MC, Winkler DT, Burgermeister P, Pfeifer M, Kohler E, Schmidt SD, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004;7:954\u201360.","journal-title":"Nat Neurosci"},{"key":"704_CR28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","volume":"1","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 2004;1:24.","journal-title":"J Neuroinflammation"},{"key":"704_CR29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","volume":"298","author":"M Pfeifer","year":"2002","unstructured":"Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M, et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 2002;298:1379.","journal-title":"Science"},{"key":"704_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.61.1.7","volume":"61","author":"PM Mathews","year":"2003","unstructured":"Mathews PM, Nixon RA. Setback for an Alzheimer\u2019s disease vaccine: lessons learned. Neurology 2003;61:7\u20138.","journal-title":"Neurology"},{"key":"704_CR31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1471-4159.2003.01556.x","volume":"84","author":"S Pype","year":"2003","unstructured":"Pype S, Moechars D, Dillen L, Mercken M. Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein. J Neurochem 2003;84:602\u20139.","journal-title":"J Neurochem"},{"key":"704_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0197-4580(01)00330-X","volume":"23","author":"DG Flood","year":"2002","unstructured":"Flood DG, Reaume AG, Dorfman KS, Lin YG, Lang DM, Trusko SP, et al. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction. Neurobiol Aging 2002;23:335\u201348.","journal-title":"Neurobiol Aging"},{"key":"704_CR33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C, et al. Abeta40 inhibits amyloid deposition in vivo. J Neurosci 2007;27:627\u201333.","journal-title":"J Neurosci"},{"key":"704_CR34","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ng.2007.23","volume":"39","author":"SA Kaeser","year":"2007","unstructured":"Kaeser SA, Herzig MC, Coomaraswamy J, Kilger E, Selenica M, Winkler DT, et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 2007;39:1437\u20139.","journal-title":"Nat Genet"},{"key":"704_CR35","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer\u2019s disease enabled by positron emission tomography. J Neurosci 2007;27:10957\u201368.","journal-title":"J Neurosci"},{"key":"704_CR36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","volume":"293","author":"J Lewis","year":"2001","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001;293:1487\u201391.","journal-title":"Science"},{"key":"704_CR37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"704_CR38","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2353\/ajpath.2007.070403","volume":"171","author":"T Bolmont","year":"2007","unstructured":"Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, et al. Induction of tau pathology by intracerebral infusion of Abeta-containing brain extract and in APP\u00d7tau transgenic mice. Am J Pathol 2007;171:2012\u201320.","journal-title":"Am J Pathol"},{"key":"704_CR39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","volume":"293","author":"J Gotz","year":"2001","unstructured":"Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001;293:1491\u20135.","journal-title":"Science"},{"key":"704_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 2004;43:321\u201332.","journal-title":"Neuron"},{"key":"704_CR41","doi-asserted-by":"crossref","unstructured":"Sigurdson CJ, Nilsson PR, Hornemann S, Manco G, Polymenidou M, Schwarz P, et al. Prion strain discrimination using luminescent conjugated polymers. Nat Methods 2007;4:1023\u201330.","DOI":"10.1038\/nmeth1131"},{"key":"704_CR42","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","volume":"313","author":"M Meyer-Luehmann","year":"2006","unstructured":"Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006;313:1781\u20134.","journal-title":"Science"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-007-0704-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-007-0704-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:37Z","timestamp":1558699297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-007-0704-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":42,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1007\/s00259-007-0704-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}